Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Optimal cholesterol treatment plans and genetic testing strategies for cardiovascular diseases.

Health care management science - 1 Mar 2021

Marrero Wesley J, Lavieri Mariel S, Sussman Jeremy B

Abstract excerpt

Atherosclerotic cardiovascular disease (ASCVD) is among the leading causes of death in the US. Although research has shown that ASCVD has genetic elements, the understanding of how genetic testing influences its prevention and treatment has been limited. To this end, we model the health trajectory of patients stochastically and determine treatment and testing decisions simultaneously. Since the cholesterol level...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticholesteremic Agents
Share to Atherosclerosis
Share to Cardiovascular Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Computer Simulation

Share to Genetic Testing

Share to Hypercholesterolemia

Share to Markov Chains

Share to Quality-Adjusted Life Years

Source

Identifiers

PMID: 33483911
DOI: 10.1007/s10729-020-09537-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Optimal cholesterol treatment plans and genetic testing strategies for cardiovascular diseases.PMID 33483911Read ↗

An evaluation of the cost-effectiveness of population genetic screening for familial hypercholesterolemia in US patients.Semantic proximity Read ↗

MSGene: Derivation and validation of a multistate model for lifetime risk of coronary artery disease using genetic risk and the electronic health recordSemantic proximity Read ↗

Cardiovascular Genetic Risk Testing for Targeting Statin Therapy in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Cost-Effectiveness Analysis.Semantic proximity Read ↗

Cost-effectiveness of cascade genetic testing for familial hypercholesterolemia in the United States: A simulation analysisSemantic proximity Read ↗

Comparison of Decision Modeling Approaches for Health Technology and Policy EvaluationSemantic proximity Read ↗

MSGene: a multistate model using genetic risk and the electronic health record applied to lifetime risk of coronary artery disease.Semantic proximity Read ↗

Value-based genomic screening: exploring genomic screening for chronic diseases using triple value principles.Semantic proximity Read ↗

Epidemiological evaluation of the use of genetics to improve the predictive value of disease risk factors.Semantic proximity Read ↗

Health economic analysis of polygenic risk score use in primary prevention of coronary artery disease – A system dynamics modelSemantic proximity Read ↗

Decision thresholds with genetic testing.Semantic proximity Read ↗

Research Protocol: Discrete choice modelling to understand the influence of sharing polygenic risk scores related to cardiovascular disease risk with primary care patientsSemantic proximity Read ↗

Cost-effectiveness of alternative cascade screening strategies for familial hypercholesterolemia with realistic cascade screening acceptance rates and use of high-cost drugsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.